MYX mayne pharma group limited

News: MYX Mayne Pharma Group Says HY Underlying EBITDA Down 16%

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Feb 24 (Reuters) - Mayne Pharma Group Ltd (MYX) :

    • HY UNDERLYING EBITDA $39.9M, DOWN 16%
    • HY REPORTED REVENUE $208.8 MILLION VERSUS $227.2 MILLION
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.00
Change
0.010(0.20%)
Mkt cap ! $406.2M
Open High Low Value Volume
$4.98 $5.03 $4.98 $593.4K 118.5K

Buyers (Bids)

No. Vol. Price($)
1 12024 $4.99
 

Sellers (Offers)

Price($) Vol. No.
$5.08 2631 2
View Market Depth
Last trade - 16.10pm 11/08/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.